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Objective To determine the occurrence of inadequate antimicrobial therapy among
critically ill patients with bacteremia and the factors associated with it, to identify the
microorganisms that received inadequate antimicrobial treatment, and to determine the
relationship between inadequate treatment and patients outcome.
Methods From June 1995 to January 1999 we collected data on all clinically significant
ICU-bacteremias in our teaching hospital. Clinical and microbiological characteristics
were recorded and the adequacy of empirical antimicrobial treatment in each case was
determined. We defined inappropriate empirical antimicrobial treatment as applying to
infection that was not being effectively treated at the time the causative microorganism
and its antibiotic susceptibility were known. Multivariate analysis was used to determine
the variables associated with inappropriate empirical antimicrobial treatment and to
evaluate the influence of this on the related mortality to bacteremia, using the SPSS
package (9.0).
Results Among 166 intensive care unit patients with bacteremia, 39 (23.5%) received
inadequate antimicrobial treatment. In this last group the mean age of patients was
64.1  13.2 years, and 64% were men. Bacteremia was hospital-acquired in 92% of these
cases. Eleven percent developed septic shock and 37.7% severe sepsis, and ultimately
fatal underlying disease was present in 28.2% of patients given inadequate empirical
antimicrobial treatment. The main sources of bacteremias in this group were: a vascular
catheter (15.3%), respiratory (7.6%) or unknown (53.8%). The microorganisms most
frequently isolated in the group with inadequate empirical antimicrobial treatment were:
coagulase-negative staphylococci (29.5%), Acinetobacter baumannii (27.3%), Enterococcus
faecalis, Pseudomonas aeruginosa, Enterobacter cloacae, Proteus mirabilis, Escherichia coli, and
Candida species (4.5% each). The frequency of coagulase-negative staphylococci in the
cases with inappropriate treatment was higher than in the group with appropriate
treatment (OR 2.62; 95% CI: 1.10–6.21; P ¼ 0.015). The global mortality rate was 56%
and the related mortality was 30% in the group with inadequate empirical antimicrobial
treatment. The only factor associated with inappropriate empirical antibiotic treatment
was the absence of abdominal or respiratory focus (P ¼ 0.04; OR ¼ 0.35; 95% CI: 0.12-0.97).
Septic shock was related to attributable mortality (P ¼ 0.03; OR ¼ 3.19; 95% CI: 1.08-9.40),
but not inappropriate empirical antibiotic treatment (P ¼ 0.24; OR¼ 1.71; 95% CI: 0.66-4.78).
Conclusion Almost a quarter of critically ill patients with bloodstream infections were
given inadequate empirical antibiotic treatment, but mortality was not higher in the
group with inadequate treatment than in the group with adequate treatment. This fact
was probably due to microbiological factors and clinical features, such as the type of
microorganism most frequently isolated and the source of the bacteremia.
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I N T R O D U C T I O N
Bloodstream infections are probably the most
serious infections of hospitalized patients requir-
ing intensive care, especially those with severe
sepsis and septic shock [1–4]. Some studies have
demonstrated an important relationship between
hospital mortality and inadequate empirical anti-
microbial treatment of infections in intensive care
unit (ICU) patients, especially those with blood-
stream infections and ventilator-associated pneu-
monia [5–8].
Antimicrobial resistance has emerged as an
important determinant of outcome for patients
in the ICU. This is largely due to the administra-
tion of inadequate empirical antimicrobial treat-
ment, which is most often related to bacterial
antibiotic resistance. The patterns of such resis-
tance clearly vary among hospitals [9]. Inadequate
empirical antimicrobial treatment has also
resulted in greater patient morbidity, higher mor-
tality rates, and increased healthcare costs [10,11].
Some microorganisms, such as vancomycin-
resistant enterococci, methicillin-resistant Staphy-
lococcus aureus (MRSA), and coagulase-negative
staphylococci (CNS), have been classically asso-
ciated with inadequate empirical antimicrobial
treatment [5,12–16]. However, their influence on
mortality is variable and dependent on the type of
microorganism and the place where the study was
done [17–20]. In a preliminary study, we did not
find significant differences in attributable mortal-
ity rates between susceptible and resistant patho-
gens in ICU bacteremias [21].
We have performed a prospective cohort study
with three main objectives: first, to determine the
occurrence of inadequate empirical antimicrobial
treatment among critically ill patients with bacter-
emia, and the factors associated with it; second, to
identify the microorganisms that received inade-
quate antimicrobial treatment; and third, to deter-
mine the relationship between inappropriate
empirical antimicrobial treatment and patient out-
come.
M A T E R I A L S A N D M E T H O D S
Study location and patients
The study was carried out in the Hospital Uni-
versitario Dr Peset (600 beds), a university-
affiliated urban teaching hospital in Valencia,
Spain. During a 43-month period (June 1995 to
January 1999), all patients admitted to the medi-
cal–surgical ICU (12 beds) were potentially eligible
for this investigation. The requirement for anti-
biotic treatment and the selection of specific anti-
microbial agents were determined by the patients’
treating physicians.
Study design and data collection
A prospective cohort study design was used, seg-
regating patients with a bloodstream infection
according to hospital survival and the adequacy of
their empirical antimicrobial treatment. Hospital-
attributable mortality was the main outcome vari-
able evaluated. The other studied variables were:
age, sex, underlying disease, nosocomial origin of
bacteremia, source of infection, severe sepsis,
septic shock, previous use of antibiotics, micro-
organism isolates, and global hospital mortality.
Definitions
Bloodstream infection was considered definitive,
and the possibility of a contaminated blood culture
was excluded, by the presence of clinical or labora-
tory evidence of infection (fever, hypothermia,
localized infection, inadequate organ perfusion,
septic shock, leukocytosis, or laboratory findings
compatible with disseminated intravascular coa-
gulopathy) [6]. Organisms that are commonly
recovered from the environment or the skin
(mainly CNS and aerobic Gram-positive rods)
were judged to be contaminants unless the clinical
findings, the results of cultures of material from
other body sites and the number of positive sets
(two or more) indicated a high probability of
bloodstream infection [6].
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For the purposes of this investigation, inap-
propriate empirical antimicrobial treatment of a
bloodstream infection was defined, following Ibra-
him et al. [5] and Kollef et al. [7], as the occurrence
of infection (i.e. a positive blood culture result) that
was not effectively treated at the time when the
causative microorganism and its antibiotic sus-
ceptibility were known. Inappropriate empirical
antimicrobial treatment included the absence of
antimicrobial agents directed at a specific class of
microorganisms (e.g. absence of therapy for fun-
gemia caused by Candida spp.) and the adminis-
tration of an antimicrobial agent to which the
microorganism responsible for the infection was
resistant (e.g. empirical treatment with oxacillin
for bacteremia subsequently attributed to MRSA
on the basis of blood culture results). It was also
necessary to consider the antibiotic treatment as
appropriate if at least one effective drug was
included in the empirical treatment, and the dose,
pattern of administration and duration of treat-
ment were according to current medical standards
[22–24]. All blood cultures for establishing the
presence of a bloodstream infection were required
to be obtained percutaneously, using sterile tech-
nique, and not drawn from indwelling vascular
catheters. Bacteremia-related mortality was diag-
nosed when a patient died during treatment for a
community-acquired or nosocomial bloodstream
infection, which could be easily explained by the
infection, and the death could not be directly
attributed to any other cause [5,23]. McCabe’s
classification [25] was used to place the patients’
underlying disease in the following categories:
rapidly fatal, ultimately fatal and non-fatal. Com-
munity-acquired bloodstream infections were
required to be established within 48 h of hospital
admission. Nosocomial bloodstream infections
were required to be established after 48 h of
hospitalization [22,26]. Nosocomial bloodstream
infections, as well as other nosocomial infections
(urinary tract, wound infection), were defined
according to criteria established by the Centers
for Disease Control and Prevention [27]. The
source of infection was designated as one of the
following: respiratory, surgical wound, vascular
catheter related, intra-abdominal, urinary tract,
unknown and others [22]. Following Rello et al.
and Valle´s et al. [22,24], abdominal and respiratory
sources of bacteremia were considered as risk foci
of infection, because these foci were associated
with a higher mortality than other sources of
bacteremia. The definitions used for the systemic
inflammatory response syndrome, sepsis, severe
sepsis and septic shock were those proposed by
the American College of Chest Physicians/Society
of Critical Care Medicine Consensus Conference
[28]. Because Enterobacteriaceae other than Escher-
ichia coli, Pseudomonas aeruginosa, Acinetobacter bau-
mannii and Candida spp. have been reported to
cause high mortality, they were considered to be
high-risk microorganisms [7,24].
Data analysis
The chi-square test was used for contingency
tables. Student’s t-test was used for comparing
means. Stepwise logistic regression analysis was
used to determine independent predictors of
related bacteremia in-hospital mortality and inde-
pendent predictors of inadequate empirical anti-
microbial treatment of bacteremia. We estimated
multivariable-adjusted odds ratios with 95% con-
fidence intervals. SPSS 9.0 software was used for
data analysis.
R E S U L T S
During the study period, 3225 consecutive eligible
patients were evaluated. Among these, 166 epi-
sodes of ICU bacteremia were detected. In 39
episodes, inappropriate empirical antimicrobial
treatment was given (23.5% of the cases of bacter-
emia). The characteristics of the 166 episodes of
ICU bacteremia according to the adequacy of
empirical antibiotic treatment are shown in
Table 1. None of these variables was statistically
different between the two groups with appropriate
and inappropriate empirical antibiotic treatment,
except that the presence of an abdominal or
respiratory focus as a source of infection was
significantly less frequent in the inadequate
empirical treatment group in the univariate ana-
lysis (12% versus 33%; P ¼ 0.01).
The commonest sources of inappropriately trea-
ted bacteremia were: unknown (53.8%), vascular
catheter (15.3%), and respiratory (7.6%). The sys-
temic response to inadequately treated bacteremia
was classified as sepsis in 16 episodes (41%),
severe sepsis in 15 episodes (38.5%), and septic
shock in four episodes (11%).
Forty-four microorganisms were isolated in the
39 episodes of bacteremia with inappropriate anti-
microbial therapy. The causative microorganisms
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of intensive care cases of bacteremia according to
the adequacy of empirical antimicrobial treatment
are listed in Table 2.
CNS (29.5%) and A. baumannii (27.3%) were the
microorganisms most frequently isolated. This
high incidence of A. baumannii bacteremia was
due to a carbapenem-resistant outbreak in our
ICU during the period of the study. Gram-positive
microorganisms were isolated in 41% of bactere-
mias with inappropriate antimicrobial treatment,
whereas Gram-negative organisms represented
54%. Statistical analysis of the influence of ina-
dequate empirical antimicrobial treatment on
attributable mortality only for patients with blood-
stream infections due to Gram-negative bactere-
mia, with and without A. baumannii, did not show
significant differences (OR 1.07, 95% CI 0.25–4.28,
P ¼ 0.574; OR 0.58, 95% CI 0.02–63.4, P ¼ 0540).
Fungemia due to Candida spp. represented only
4.5% of the isolates. The frequency of CNS in the
cases with inappropriate treatment was higher
than in the group with appropriate treatment
(OR 2.62, 95% CI 1.10–6.21, P ¼ 0.015).
Logistic regression showed that the only risk
factor associated with the administration of inade-
quate treatment was the absence of an abdominal
or respiratory focus of bacteremia (OR ¼ 0.35, 95%
CI 0.12–0.97, P ¼ 0.04).
Multivariate analysis failed to demonstrate that
inadequate treatment, risk source of infection,
isolation of a risk microorganism and nosocomial
origin of bacteremia were associated with related
Table 2 Microorganisms causing cases of intensive care bacteremia according to the adequacy of empiric antimicrobial
treatment
Microorganisms
Inadequate empirical
antimicrobial treatment
No. (%)
Adequate empirical
antimicrobial treatment
No. (%)
Coagulase-negative staphylococci 13 (29.5)a 21 (13.8)a
Acinetobacter baumannii 12 (27.3) 30 (19.7)
Enterococcus spp. 2 (4.5) 13 (8.5)
Staphylococcus aureus 2 (4.5) 15 (9.8)
Pseudomonas aeruginosa 2 (4.5) 17 (11.1)
Enterobacter cloacae 2 (4.5) 3 (2)
Proteus mirabilis 2 (4.5) 2 (1.3)
Escherichia coli 2 (4.5) 18 (11.8)
Candida albicans 2 (4.5) 0 (0)
Klebsiella pneumoniae 1 (2.3) 4 (2.6)
Salmonella spp. 1 (2.3) 0 (0)
Citrobacter freundii 1 (2.3) 0 (0)
Serratia marcescens 1 (2.3) 0 (0)
Streptococcus mutans 1 (2.3) 0 (0)
Others 0 (0) 29 (19.1)
Total 44 (100) 152 (100)
aCoagulase-negative staphylococci were the only organisms with significant differences, P ¼ 0.015.
Table 1 Characteristics of 166 cases of intensive care bacteremia according to the adequacy of empirical antimicrobial
treatment
Adequate treatment
N ¼ 127
Inadequate treatment
N ¼ 39 P
Male/female (%) 60.6/39.4 64.1/35.9 0.697
Years of age (mean  SD) 63.2  16.3 64.2  13.2 0.733
Nosocomial origin of the bacteremia (%) 79.5 92.3 0.066
Ultimately fatal disease (%) 33.8 28.2 0.640
Respiratory or abdominal source
of the bacteremia (%)
33.6 12.1 0.017
High-risk microorganisms (%) 34.9 42.1 0.420
Previous antibiotic treatment (%) 62.2 74.3 0.164
Severe sepsis or septic shock (%) 58.3 48.7 0.293
Global mortality (%) 50.3 56.4 0.512
Related mortality (%) 22.8 30.8 0.315
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mortality. The presence of septic shock at the
moment of bacteremia was the only related factor
with attributable mortality in our study (OR ¼
3.19, 95% CI 1.08–9.40, P ¼ 0.03).
D I S C U S S I O N
It is well known that the presence of bloodstream
infection is a risk factor for the administration of
inadequate empirical treatment of infections [7]. In
our setting, 23.5% of patients with cases of ICU
bacteremia received inappropriate empirical anti-
microbial treatment. Similar percentages have
been described by several authors, varying
between 20% and 30% [5,6,24].
Previous studies have identified an important
association between the administration of inade-
quate antimicrobial treatment of bloodstream
infections and hospital mortality [5–8,22]. Ibrahim
et al. [5] found an important reduction in fatality in
patients receiving appropriate treatment (61.9%
versus 28.4%, RR 2.18), and Leibovici et al [6]
demonstrated that the contribution of inappropri-
ate empirical antimicrobial treatment to fatality
was independent of other risk factors in a multi-
variate logistic analysis.
However, our study failed to demonstrate this
relationship between attributable mortality and
the administration of inappropriate empirical anti-
microbial treatment in patients with ICU bacter-
emia. To our knowledge, this is the first study to
find no differences in mortality rates between
critically ill patients with a bloodstream infection
who received inappropriate empirical antimicro-
bial treatment and those who were given appro-
priate treatment.
Factors such as the source of the bacteremia and
the microorganism isolated may explain our
results, in part. The presence of abdominal or
respiratory foci as risk sources of infection was
significantly less frequent in the inadequate treat-
ment group in the univariate analysis (12% versus
33%, P ¼ 0.01) in our setting. It is well recognized
that the mortality rate of cases of ICU bacteremias
depends on the source of the bacteremia. Classi-
cally, urinary and vascular catheter foci have been
associated with better outcome, and pulmonary
and intra-abdominal foci with the worst prognosis
[22,24,29,30]. Valle´s and the Spanish collaborative
group for Infections in Intensive Care Units [24]
demonstrated that the source of bacteremia other
than intravascular catheters was a risk factor asso-
ciated with bacteremia-related mortality. Rello
et al. [22] found an important relationship between
an intra-abdominal origin of infection and hospital
mortality, and Leibovici et al. [6], in a stratified
analysis, demonstrated that the highest benefit of
appropriate antibiotic treatment was apparent in
intra-abdominal infections and infections of skin
and soft tissues, whereas all the other sources of
bacteremia were comparable. The low prevalence
of risk foci of infection in the inadequate treatment
group, as described above, may be, responsible for
our results in part. The reason why patients with
respiratory or abdominal foci of infection were
more frequently treated with inadequate empirical
antimicrobial treatment than patients with other
foci of infection was probably the fact that this type
of infection followed a standardized treatment
regimen in our ICU. Microbiological factors can
also influence the outcome of sepsis. The most
commonly identified bloodstream pathogens asso-
ciated with inadequate treatment described in
several reports were vancomycin-resistant enter-
ococci, MRSA, CNS, P. aeruginosa, Enterobacter,
Acinetobacter, and Candida spp. [5,13–16]. How-
ever, to date, the evidence with MRSA and van-
comycin-resistant enterococci is inconsistent with
regard to the effect on mortality rates [17–19],
although the use of vancomycin was associated
with increased mortality [20]. Similar findings
were previously reported by our group, which
did not find significant differences in attributable
mortality rates between susceptible and resistant
pathogens in cases of ICU bacteremia [21].
Furthermore, Rangel-Frausto [31] found that bac-
teremia caused by Candida and Enterococus spp.
was associated with the highest attributable mor-
tality (30–40%), and CNS were associated with the
lowest attributable mortality (15–20%). We did not
find differences in the percentage of high-risk
microorganisms between the groups with appro-
priate and inappropriate treatment, but the fre-
quency of CNS (33.3%) in the cases with
inappropriate treatment was higher than in the
group with appropriate treatment (16.3%) (OR
2.62, 95% CI 1.10–6.21, P ¼ 0.015). This fact may
also contribute to the absence of benefit of the
administration of adequate treatment in our study,
due to the low mortality of cases of CNS bacter-
emia in critically ill patients [24,31].
A bloodstream infection attributed to Candida
spp., prior administration of antibiotics during the
same hospitalization, decreasing serum albumin
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concentrations and increasing central catheter
duration were factors described by Ibrahim et al.
[5] as being independently associated with the
administration of inadequate antimicrobial treat-
ment. No factors other than the absence of an
abdominal or a respiratory source of infection
were associated with the administration of inade-
quate treatment in our study. Finally, other factors
that have been independently associated with a
higher directly related mortality to bacteremia as
well as inappropriate treatment, are severe sepsis
or septic shock, development of multi-organ fail-
ure or number of organ dysfunctions, adult
respiratory distress syndrome, acute renal failure,
APACHE II score at the onset of sepsis, Gram-
negative bacteremia or candidal bacteremia, and
abdominal or respiratory foci [22–24]. Septic shock
was the only factor associated with attributable
mortality in our study. Inappropriate treatment,
risk focus of infection and risk microorganism
were not related to attributable mortality in this
study, probably due to the limited number of cases
in our setting.
C O N C L U S I O N S
Although the administration of inappropriate
empirical antimicrobial treatment to patients with
ICU bacteremia was high in our study, we did not
find an excess of attributable mortality in this
group, probably due to microbiological factors
and clinical features such as the type of microor-
ganism most frequently isolated and the source of
bacteremia involved.
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